These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31788243)

  • 1. Correction to: Patients' usability of seven most used dry-powder inhalers in COPD.
    Dal Negro RW; Turco P; Povero M
    Multidiscip Respir Med; 2019; 14():39. PubMed ID: 31788243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' usability of seven most used dry-powder inhalers in COPD.
    Dal Negro RW; Turco P; Povero M
    Multidiscip Respir Med; 2019; 14():30. PubMed ID: 31528340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference.
    Dal Negro RW; Povero M
    Multidiscip Respir Med; 2016; 11(1):31. PubMed ID: 27597888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.
    Chapman KR; Fogarty CM; Peckitt C; Lassen C; Jadayel D; Dederichs J; Dalvi M; Kramer B
    Int J Chron Obstruct Pulmon Dis; 2011; 6():353-63. PubMed ID: 21760722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy.
    Dal Negro RW; Povero M
    Children (Basel); 2021 Dec; 9(1):. PubMed ID: 35053653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.
    Voshaar T; Spinola M; Linnane P; Campanini A; Lock D; Lafratta A; Scuri M; Ronca B; Melani AS
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):363-70. PubMed ID: 24299501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
    Yun Kirby S; Zhu CQ; Kerwin EM; Stanford RH; Georges G
    COPD; 2016; 13(2):167-75. PubMed ID: 26516724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum to: Recent advances in capsule-based dry powder inhaler technology.
    Lavorini F; Pistolesi M; Usmani OS
    Multidiscip Respir Med; 2017; 12():19. PubMed ID: 28652914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β
    Wittbrodt ET; Millette LA; Evans KA; Bonafede M; Tkacz J; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2019; 14():101-114. PubMed ID: 30613140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
    Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
    BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
    Franks M; Briggs P
    Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usability and Robustness of the Wixela Inhub Dry Powder Inhaler.
    Allan R; Canham K; Wallace R; Singh D; Ward J; Cooper A; Newcomb C
    J Aerosol Med Pulm Drug Deliv; 2021 Apr; 34(2):134-145. PubMed ID: 32865454
    [No Abstract]   [Full Text] [Related]  

  • 18. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder inhalers - between the doctor and the patient.
    Emeryk A; Pirożyński M; Emeryk-Maksymiuk J
    Adv Respir Med; 2018; 86(1):44-52. PubMed ID: 29490421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.